Cargando…

CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer

Tumor-associated macrophages (TAMs) are among the main contributors to immune suppression in the tumor microenvironment, however, TAM depletion strategies have yielded little clinical benefit. Here, we discuss the concept that TAMs are also key regulators of anti-PD(L)-1-mediated CD8 T cell-dependen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marcovecchio, Paola Marie, Thomas, Graham, Salek-Ardakani, Shahram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919587/ https://www.ncbi.nlm.nih.gov/pubmed/33637602 http://dx.doi.org/10.1136/jitc-2020-002045

Ejemplares similares

Prebiotics: Ignored player in the fight against cancer
por: Mishra, Parichita, et al.
Publicado: (2023)

Stevia, Nature’s Zero-Calorie Sustainable Sweetener: A New Player in the Fight Against Obesity
por: Ashwell, Margaret
Publicado: (2015)

IFN-γ: A Crucial Player in the Fight Against HBV Infection?
por: Hillaire, Marine Laure Bettina, et al.
Publicado: (2023)

The Effect of Transplantation of Cultured Autologous Melanocytes on CXCL9, CXCL10 and CXCL11 Expressions in Vitiligo
por: Xu, Chen, et al.
Publicado: (2023)

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression
por: Beider, Katia, et al.
Publicado: (2022)

OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8(+) T‐cell vaccines against respiratory viruses
por: Goulding, John, et al.
Publicado: (2011)

An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance
por: Adesanya, Oluwafolajimi, et al.
Publicado: (2020)

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011)

New Insights in the Fight against HIV
por: Trabattoni, Daria, et al.
Publicado: (2021)

EZH2 as a Regulator of CD8+ T Cell Fate and Function
por: Stairiker, Christopher J., et al.
Publicado: (2020)

Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis
por: Yeo, L, et al.
Publicado: (2016)

Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis
por: Furuya, Mitsuko, et al.
Publicado: (2012)

Self-defense of macrophages against oxidative injury: Fighting for their own survival
por: Virág, László, et al.
Publicado: (2019)

Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game
por: Través, Paqui G., et al.
Publicado: (2012)

CXCL9: evidence and contradictions for its role in tumor progression
por: Ding, Qiang, et al.
Publicado: (2016)

Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
por: Gauthier, Thierry, et al.
Publicado: (2022)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
por: Najmaddini, Hamid, et al.
Publicado: (2014)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022)

Macrophage polarization by MSC-derived CXCL12 determines tumor growth
por: Babazadeh, Shabnam, et al.
Publicado: (2021)

CXCL8, CXCL9, and CXCL10 serum levels increase in syphilitic patients with seroresistance
por: Dong, Xiaoyan, et al.
Publicado: (2021)

Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
por: Nogueira, Luciana Gabriel, et al.
Publicado: (2012)

Macrophage adaptation in airway inflammatory resolution
por: Kaur, Manminder, et al.
Publicado: (2015)

Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
por: Chanmee, Theerawut, et al.
Publicado: (2014)

Tumor-associated macrophages: an effective player of the tumor microenvironment
por: Basak, Udit, et al.
Publicado: (2023)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003)

Development of a new HISCL automated CXCL9 immunoassay
por: Hasegawa, Takehiro, et al.
Publicado: (2023)

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy
por: Pascual-García, Mónica, et al.
Publicado: (2019)

Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner
por: Mundra, Jyoti Joshi, et al.
Publicado: (2016)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
por: Matsumoto, Ari, et al.
Publicado: (2023)

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
por: Riedel, Jan-Hendrik, et al.
Publicado: (2023)

CD8(+) T Cell Exhaustion in Cancer
por: Dolina, Joseph S., et al.
Publicado: (2021)

THE FIGHT AGAINST CANCER
Publicado: (1962)

The Fight against Tuberculosis
Publicado: (1921)

Fight against Epidemics
Publicado: (1920)

The Fight against Disease
Publicado: (1921)

The Fight against Tuberculosis
Publicado: (1920)

Fight against Disease
Publicado: (1914)

New Strategies to Fight against Sarcopenia at Old Age
por: Meynial-Denis, Dominique, et al.
Publicado: (2012)

Opening up new fronts in the fight against cholesterol
por: DeBose-Boyd, Russell A, et al.
Publicado: (2013)

New Hope in Fight against Sickle Cell Anemia?
por: Damle, S. G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hakejq8ejt2ce1l5b3oi677lv0